The only known source of vitamin B12 (adenosylcobalamin) is from bacteria and archaea, and the only unknown step in its biosynthesis is the production of the intermediate adenosylcobinamide phosphate. Here, using genetic and metabolic engineering, we generated an Escherichia coli strain that produces vitamin B12 via an engineered de novo aerobic biosynthetic pathway. Excitingly, the BluE and CobC enzymes from Rhodobacter capsulatus transform L-threonine into (R)-1-Amino-2propanol O-2-Phosphate, which is then condensed with adenosylcobyric acid to yield adenosylcobinamide phosphate by either CobD from the aeroic R. capsulatus or CbiB from the anerobic Salmonella typhimurium. These findings suggest that the biosynthetic steps from co(II)byrinic acid a,c-diamide to adocobalamin are the same in both the aerobic and anaerobic pathways. Finally, we increased the vitamin B12 yield of a recombinant E. coli strain by more than ~250-fold to 307.00 µg/g DCW via metabolic engineering and optimization of fermentation conditions. Beyond our scientific insights about the aerobic and anaerobic pathways and our demonstration of E. coli as a microbial biosynthetic platform for vitamin B12 production, our study offers an encouraging example of how the several dozen proteins of a complex biosynthetic pathway can be transferred between organisms to facilitate industrial production. KEY WORDS: vitamin B12, E. coli, co(II)byrinic acid a,c-diamide, adenosylcobinamide phosphate, (R)-1-Amino-2-propanol O-2-Phosphate
INTRODUCTION
Strong demand from the food, feed additive, and pharmaceutical industries has recently sparked strong interest in the use of bacteria to produce vitamin B12 (adenosylcobalamin) 1 . To date, the industrial production of vitamin B12 is mainly from fermentation of Pseudomonas denitrifians and Propionibacterium shermanii, but these strains grow slow and are difficult to engineer. Thus, the engineering of the de novo vitamin B12 biosynthetic pathway in a fast-growing, genetically tractable species like E. coli is attractive as an alternative production platform. However, given that the de novo biosynthetic pathway contains around 30 genes that would need to be expressed heterologously, the successful production of vitamin B12 represents a significant engineering challenge.
In nature, vitamin B12 is synthesized de novo in some bacteria and archaea using one of two alternative pathways: the aerobic pathway (represented by P. denitrifians) and the anaerobic pathway (represented by S. typhimurium). The major differences between the two pathways relate to the time of cobalt insertion and the requirement for oxygen 2 . In the aerobic pathway, cobalt insertion occurs on hydrogenobyrinic a,cdiamide (HBAD) and is catalyzed by the CobNST complex at a late pathway stage, and oxygen is required to promote ring-contraction 3 . In the anaerobic pathway, cobalt insertion occurs on factor II and is catalyzed by CbiK at an early stage 4 . Research using an ingenious enzyme-trap method to trap and identify pathway intermediates has been used to elucidate the biosynthetic mechanism of corrin ring formation for both the aerobic and anaerobic pathways 5, 6 .
In the aerobic pathway, uroporphyrinogen III (Uro III) is converted to hydrogenobyrinic acid (HBA) via a series of C-methylations and decarboxylations as well as a ring contraction ( Fig. 1 ). Subsequently, HBA is converted to HBAD through amidations of carboxyl groups at positions a and c by the CobB enzyme in P. denitrifians 7 . HBAD is converted to co(II)byrinic acid a,c-diamide (CBAD) after cobalt insertion, and CBAD then undergoes co(II)rrin reduction, adenylation, and amidations of carboxyl groups at positions b, d, e, and g to yield adenosylcobyric acid (AdoCby) 8, 9 . It has been assumed that adenosylcobinamide (AdoCbi) is synthesized via the attachment of (R)-1-Amino-2-propanol (AP) to AdoCby to yield AdoCbi in a single step reaction that is catalyzed by a two-component system (designated as α and β in P. denitrificans (Fig. 1) ; the β component is known to comprise the CobC and CobD enzymes in this organism, but the α protein component remains unidentified) 9 . AdoCbi then undergoes phosphorylation to form AdoCbi-P before the final addition of a GMP moiety by the bifunctional enzyme CobP to yield AdoCbi-GDP.
In the anaerobic pathway of S. typhimurium: AdoCbi-P is biosynthesized through the attachment of (R)-1-Amino-2-propanol O-2-Phosphate (APP) to AdoCby as catalyzed by an adenosylcobinamide-phosphate synthase CbiB (Fig. 1) 10 . APP is synthesized from L-threonine by PduX and CobD 11, 12 . AdoCbi-P is transformed into AdoCbi-GDP through the addition of a GMP moiety by CobU 13 . Two additional known reactions transfer lower axial ligands onto AdoCbi-GDP, thus producing adenosylcobalamin (AdoCbl) 14, 15 .
It has been reported that a recombinant E. coli expressing vitamin B12 biosynthetic genes from P. denitrifians ATCC 13867 produced 0.65 ± 0.03 μg/g DCW vitamin B12 16 ; however, this report did not include unambiguous chemical evidence of AdoCbl production, as the microbiological assay used is nonspecific for AdoCbl detection and is known to sometimes yield false positives 17 . Further, given that protein α has not been identified in the de novo aerobic vitamin B12 biosynthetic pathway, AdoCbi-P (an intermediate of the pathway) was not produced in that study. Thus, to date there has been no demonstration of vitamin B12 production in E. coli.
Here, seeking to engineer a de novo aerobic vitamin B12 biosynthetic pathway in E. coli, we needed to determine how AdoCbi-P is synthesized. It also bears mention that there have been no reports CBAD production in a heterologous host, although in vitro assays have been reported previously. These two issues are the key problems that we tackle in this study. By comparing and contrasting in vitro and in vivo CBAD biosynthesis reactions, we determined that cobalt uptake transport proteins are necessary participants for cobalt chelation. We also confirmed that the bluE, cobC, and cobD genes from R. capsulatus are functional homologues of, respectively, pduX, cobD, and cbiB from S.
typhimurium.
We successfully engineered E. coli to produce vitamin B12 by heterologously expressiing of a total of 28 
RESULTS

Biosynthesis of CBAD in E. coli
We started the construction of the de novo vitamin B12 biosynthetic pathway using E. coli strain MG1655 (DE3) into which we transformed the pET28-HBA plasmid (Supplementary Data 1) to enable it to synthesize HBA, resulting in strain FH001. FH001 was cultured in 2×YT medium, and produced 0.73 mg/g DCW HBA (HPLC analysis). We then expressed the pCDFDuet-1 plasmid harboring cobB from R. capsulatus in FH001 and thereby generated the HBAD-producing strain FH131
( Supplementary Fig. 1 ); LC-MS analysis showed that FH131 could produce 0.17 mg/g DCW HBAD (Fig. 2b ).
We conducted a series of in vitro assays to support our identification of functional CobN, CobS, and CobT enzymes for the production of CBAD. To increase the likelihood of obtaining functional versions of these three enzymes, three variants from Sinorhizobium meliloti 320 18 , Brucella melitensis, and R. capsulatus were tested (total of 9 enzymes tested). Note that the substrate HBAD is not commercially available, so we purified it from an HBAD-producing strain via an enzyme-trap method. Previous work has established that purified CobN protein can bind to its substrate HBAD 3 , so we expressed the cobN genes from B. melitensis, S. meliloti, and R. capsulatus with N terminal fusion hexa-histidine tags using the pCDF-cobB plasmid and transformed these into the FH001 strain, respectively generating strains FH159, FH160, and FH161.
Cultures of these strains were used to purify CobN and HBAD complexes via the enzyme-trap method detailed in the Methods section, and after boiling, LC-MS analysis showed that HBAD could be detected in all samples ( Supplementary Fig. 2 ), thereby demonstrating that CobN can bind its substrate HBAD without the aid of CobS or CobT.
We next attempted to purify CobS and CobT from S. meliloti 320, B. melitensis, and R. capsulatus. Unfortunately, the CobT proteins were prone to precipitate during purification. We therefore temporarily shifted our focus to examine CobT denaturation:
given that CobS and CobT have a common evolutionary origin with, respectively, the magnesium chelatase subunits BchI and BchD 19 , and considering that BchI is known to be a chaperone essential for the function of the BchD magnesium chelatase subunit 20 Supplementary Fig. 3 ). We found that when CobS was present we did not observe CobT precipitation. Having overcome this issue with CobT, we next conducted in vitro assays with HBAD, CobN, CobS, and CobT and used LC-MS to confirm their activity: CBAD was formed when the substrate HBAD, the three enzymes, and cobalt chloride were all present, but was not detected in the cotrol group lacking cobalt chloride ( Supplementary Fig. 4, 5 and Supplementary Note 1).
Having confirmed the ability of CobN, CobS, and CobT to produce CBAD in vitro, we next expressed these proteins in vivo to synthesize CBAD. Initially we used the cobB gene from R. capsulatus and cobN (with a fused N-terminal hexa-his tag to increase translation efficiency; SDS-PAGE analysis shown in Supplementary Fig. 7 ), cobS, and cobT genes from S. meliloti 320, B. melitensis or R. capsulatus (expressed as pseudo-operons) on a single plasmid (Module 2). LC-MS analysis of these strains did not detect CBAD, and these discrepencies in the results from the in vivo vs. in vitro assays prompted us to consider how cobalt metabolism may have affected biosynthesis in our E. coli cells. It has been previously reported that the heterologous expression in E. coli of the CbiM,N,Q,O proteins from S. typhimurium or from R. capsulatus enables cobalt uptake 21 . To this end, a plasmid carrying genes for these four proteins (Module 3) was co-transformed into the FH001 strain alongside plasmids harboring Module 2, generating strains FH163, FH164, and FH165 (a separate strain for each of the Module 2 variants, see above).
In agreement with our hypothesis, each of these strains could produce CBAD, demonstrating the necessity of cobalt uptake transporters for cobalt chelation (Fig. 2 ).
FH164 had the highest CBAD yield among these three strains. Module 3 was then integrated into the E. coli genome and the endA gene (encoding DNA-specific endonuclease I) was deleted, resulting in strain FH215. When the plasmids pET28-HBA (Module 1) and pCDF-cobB-BmcobN-his-BmcobS-BmcobT (Module 2) were transformed into FH215, CBAD could be produced in the new strain FH216, which was subsequently used as the CBAD-producing strain for our continued engineering of vitamin B12 production in E. coli. However, the Km value for (R)-1-Amino-2-propanol was very high (20 mM 22 ), suggesting that (R)-1-Amino-2-propanol might not be the true substrate for this APsynthesizing complex. Interestingly, we found that homologues of the anaerobic pathway genes pduX, cobD, and cbiB from S. typhimurium are present in genome of the aerobic-pathway-utilizing R. capsulatus as, respectively, the blue, cobC, and cobD genes.
Biosynthesis of (R)-1-Amino-2-propanol O-2-Phosphate in E. coli
It thus appears likely that the aerobic and anaerobic pathways employ the same biosynthetic reactions to produce APP and AdoCbi-P. To test this hypothesis, blue and cobC from R. capsulatus, which encode potential L-threonine kinase and threonine-O-3-phosphate decarboxylases, respectively, were assayed in vitro and in vivo. BluE and PduX were initially expressed at a very low level from the pACYCduet-1 plasmid . To minimize locally stabilized mRNA secondary structures and thereby enable efficient translation initiation of the bluE and pduX transcripts, two bicistronic vectors were designed. In the first plasmid (pACYC-MBP-bluE), a sequence derived from the first 10 amino acids of the maltose binding protein (MBP) was placed located upstream of the second codon-optimized bluE sequence ( Supplementary Fig. 8a, b ). In the second plasmid (pACYC-his-pduX), a sequence derived from a his tag is located upstream of the second pduX seqcuence ( Supplementary Fig. 8c, d ). SDS-PAGE analysis showed that the expression level of bluE and pduX were significantly improved in strains carrying this system ( Fig. 3b ). As BluE degenerated almost completely during pufication, crude BluE activity was confirmed via an in vitro assay ( Supplementary Fig.   9 ). The activity of RcCobC (CobC from R. capsulatus) was also confirmed via in vitro assays ( Supplementary Fig. 10 ). The Km and Vmax values of RcCobC were measured to be 25.6 µM/min and 1.89 mM, respectively.
Given that E. coli has an endogenous pathway to produce AP ( Fig. 3a) , we deleted the gldA gene from E. coli MG1655 (DE3); the resulting strain was designated as FH291. We then designed and introduced an AP pathway into FH291 to confirm the functions of BluE/PduX and RcCobC/StCobD in vivo ( Fig. 3c, d strains. We also deleted the genes encoding PhoA (an alkaline phosphatase) and AphA (an acid phosphatase) successively in FH297 and FH300. However, as each of these strains still produced AP, the phosphatase that converts APP to AP in E. coli is not yet clear.
De novo biosynthesis of vitamin B12 in E. coli
AdoCby is formed from CBAD in three steps. In the first step, CBAD is reduced to cob(I)yrinic acid a,c-diamide by an NADH-dependent flavoenzyme that (in aerobic Pseudomonas denitrificans) exhibits cob(II)yrinic acid a,c-diamide reductase activity.
However, the gene encoding this enzyme has not been identified. The cobR gene from aerobic B. melitensis has been demonstrated to encode a biosynthetic enzyme with co(II)rrin reductase activity 23 . In the next biosynthesis step of the known pathway, cob(I)yrinic acid a,c-diamide is transformed to its adenosyl form by an adenosyltransferase. In some bacteria, identical adenosyltransferases catalyze adenosylation reactions on cobinamide in a salvage pathway. Therefore, the adenosyltransferase BtuR of E. coli in the salvage pathway might function on the substrate cob(I)yrinic acid a,c-diamide.
To explore this idea, the strain FH216 was used as the host cell for functional Finally, two recombinant strains FH218 (with pduX, cobD, and cbiB from S. typhimurium) and FH219 (with bluE, cobC, and cobD from R. capsulatus) harboring Modules 1-5 were obtained ( Fig. 4a ). We supplemented the CM medium with Lthreonine to circumvent the need to engineer the supply of this amino acid in host cells.
Our dectection of vitamin B12 by LC-MS and comparison of its retention time and spectrum with the chemical reference standard demonstrated the successful assembly of our completed engineered de novo vitamin B12 biosynthesis pathway in recombinant strains FH218 and FH219. Beyond this bioengineering result, our successful demonstration of vitamin B12 in this system confirms the scientific fact that APP participates in the biosynthesis of AdoCbi-P in both the aerobic and anaerobic pathways ( Fig. 4 ). However, FH218 and FH219 produced only 2.18 μg/g DCW and 1.22 μg/g DCW vitamin B12, respectively ( Supplementary Fig. 11 ), and it should be noted that HBA was not detected in FH164, a finding which suggested the idea that HBA availability may be a limit to CBAD synthesis.
Increasing the HBA pool increased vitamin B12 production
Vitamin B12 and other tetrapyrrole compounds including heme, siroheme, and coenzyme F430 each originate from δ-aminolevulinate (ALA). ALA is synthesized via either a C4 or C5 pathway 25 . In the C4 pathway, glycine and succinyl-CoA are condensed by ALA synthase (encoded by either hemA or hemO) to form ALA. In the C5 pathway, ALA is synthesized from glutamate via a three-step reaction catalyzed successively by the enzymes Gltx, HemA, and HemL 26 . Then, 8 molecules of ALA undergo condensation, polymerization, and cyclization to form Uro III, which is a precursor for the biosynthesis of vitamin B12, heme, and coenzyme F430 27 .
Given that the cobAIGJMFKLH operon is driven by a strong T7 promoter, we heterologously expressed the hemO, hemB, hemC, and hemD genes (the pathway components from ALA to Uro III) with the aim of converting additional precursor molecules into HBA. HemO from R. palustris and HemB, HemC, and HemD from S. meliloti were expressed as a polycistronic product in the FH001 strain, which boosted HBA production from 0.54 mg/g DCW to 6.43 mg/g DCW after 20 h of growth, albeit with reduced overall growth ( Supplementary Fig. 12 ). Our experiments showed that HBA production in the FH001 strain gradually decreased from 8 h to 38 h. However, HBA production of FH168 peaked at 20 h and then gradually decreased, highlighting that the accumulation of precursors from ALA to Uro III does boost HBA production in FH168. We speculate that this apparent gradual decrease in HBA levels from 20 h to 38 may related to HBA stability or perhaps the decreased catalytic function of the heterologous enzymes over time.
In addition, the maximum ALA yields for the FH001 and FH168 strains were 0.10 g/L and 0.67 g/L, respectively, confirming that the expression of heterologous ALA synthase boosted ALA production. Expression of a polycistronic product from a hemOBCD gene cluster lead to heme accumulation and was toxic 28 . To decrease the formation of heme, we used a small RNA strategy 29 to knockdown the expression of hemE, hemF, hemG, and hemH in FH168 ( Supplementary Fig. 13 ). The FH187 strain (hemG knockdown) had the highest HBA yield at 9.34 mg/g DCW, a 45.26% increase over FH168. We then assessed 6 strains that had the expression of two of their heme biosynthesis genes simultaneously knocked down via small RNA ( Supplementary Fig.   14 
Genetic modifications of cobalt chelatases and Cbi module increased vitamin B12 production
The gap between the production of HBAD of FH273 and vitamin B12 of FH309 implied that metabolic bottlenecks might exist among cobalt chelatases and Cbi module. In addition, HBAD accumulated in FH309 ( Supplementary Fig. 15 ), suggesting that the cobalt chelation step is indeed a bottleneck. Therefore, recombinant strains expressing cobalt chelatases from B. melitensis, S. meliloti, or R. capsulatus were evaluated for vitamin B12 production ( Fig. 5a, b ). The strain with the cobalt chelatase from R. capsulatus (FH329) had highest vitamin B12 production among these strains, at 21.96 µg/g DCW. In addition, 6 recombinant E. coli strains variously expressing combinations of the CobN, CobS, and CobT enzymes from different bacterial species were also evaluated for vitamin B12 production. These strains produced vitamin B12 in amounts ranging from 2.19 µg/g DCW to 11.22 µg/g DCW (Fig. 5c ).
A review article has speculated that the enzyme CobW may somehow function in the delivery and presentation of cobalt to CobN 30 , so we investigated how the expression of CobW might improve vitamin B12 production. Interestingly, vitamin B12 production increased in 5 of the 9 recominant strains in which we expressed various cobW homologs (Fig. 5 ). The strain FH351 expressing cobW from B. melitensis achieved the highest vitamin B12 production, at 68.61 µg/g DCW, a 14.9-fold increase over the original strain lacking cobW.
After optimizing the cobalt chelatases, we tested a multiple variants of the downstream Cbi module with the aim of further improving vitamin B12 production.
Most of the metabolic intermediates between CBAD and AdoCbl are instable and unavailable commercially, which limited our ability to conduct in vitro enzyme kinetics assays or to probe each step in vivo to identify specific bottlenecks. It is well-established that the expression of enzyme variants can help to increase metabolic flux toward traget products 31 . Thus, Cbi module variants comprising enzymes from various bacteria were examined (Fig. 5) , and among the strains expressing CobW, strain FH364 (expressing cobR from B. melitensis, StcobA, cbiP, pduX, StcobD and cbiB from S. typhimurium) had the highest vitamin B12 production at 171.81 µg/g DCW. It is noteworthy that three strains harboring the bluE-RccobC-cbiB expression cassette (FH362, FH363, and 
Optimization of fermentation conditions increased vitamin B12 production
In order to provide an optimal growth medium for the engineered strains, the concentrations of key precursors such as glycine, succinic acid, and betaine were optimized in the medium ( Supplementary Table 1 and Supplementary Fig. 16 ). Vitamin B12 production of FH364 increased to 255.68 µg/g DCW when cultured in the optimized modified CM medium. We then altered growth temperatures and IPTG induction concentrations, as these are known to influence heterologous protein expression (Supplementary Table 2 and Supplementary Fig. 17 ). We found that growth temperature has a greater influence on vitamin B12 production than IPTG concentrations: low temperature is conducive to the expression of soluble proteins and to correct folding, while high temperature is conducive to bacteria growth. Vitamin B12 production increased from 24 °C to 32 °C, and then declined sharply at 37 °C. Cell growth rates increased slightly from 24 °C to 30 °C, but decreased from 30 °C to 37 °C. Induction at 0.1 mM IPTG resulted in the lowest vitamin B12 production observed for each temperature, and we found that the optimal IPTG concentrations were different for each culture temperature. Collectively, we found that the optimal conditions for is maximal vitamin B12 production is a growth temperature of 32 °C and an IPTG concentration of 1 mM: under these optimized conditions the vitamin B12 yield of the top-performing FH364 strain increased from 171.81 up to 307.00 µg/g DCW (equal to 0.67 mg/l).
DISCUSSION
The biosynthetic pathway of vitamin B12 is very complex and although most of the biosynthetic pathway steps have been elucidated, the process through which AdoCbi-P is synthesized in the aerobic vitamin B12 biosynthetic pathway remains unknown.
Seeking to replace the traditionally used industrial strains for vitamin B12 production, we here chose E. coli as the heterologous host to introduce an engineered de novo aerobic vitamin B12 biosynthetic pathway. Most of the intermediate molecules of the vitamin B12 biosynthetic pathway are not commercially available, which complicates the verification of the functions of candidate enzymes, so we used a "bottom-up" strategy that integrating genetic and metabolic engineering strategies to develop our engineered vitamin B12-producing E. coli strain. Based on rational knowledge of the aerobic pathway, we divided the 32 genes known to be involved in the pathway into 6 separate modules, which facilitated our characterization of each aspect of the design.
Ultimately, our efforts led to the first demonstration of complete vitamin B12 production in E. coli.
It has been reported that the cobN, cobS, and cobT genes from B. melitensis and P. denitrifians can produce CBAD production in vitro 3, 19 . However, it is understood that the mechanism of cobalt chelation in vivo is more complicated than that in vitro 3, 19 . We here characterized the role of cobalt transporters in facilitating cobalt chelation. We used in vitro assays to successfully confirm the CBAD-production-related functions of CobN, CobS, and CobT enzymes from B. melitensis, R. capsulatus, and S. meliloti, but found that the expression of the genes encoding these enzymes in E. coli did not result in CBAD production in cells, ostensibly because these cells lacked the essential substrate cobalt. Consistent with this idea, the expression in these cells of the cobalt uptake transport proteins CbiM, CbiN, CbiQ, and CbiO led to CBAD production, thus establishing that having a cobalt uptake transport system is essential for de novo vitamin B12 biosynthesis using the aerobic pathway in E. coli. This may be a requirement for vitamin B12 biosynthesis in all bacteria: consider for example that an ABC-type cobalt transport system (CbtJKL) is essential for growth of S. meliloti at trace metal concentrations 32 and that the B12 biosynthesis superoperon of S. typhimurium includes the cbiMNQO gene cassette 17 .
Importantly, our study overturned previous assumptions about the aerobic pathway that AP is condensed with AdoCby to form AdoCbi before undergoing a subsequent CobU from S. typhimurium is a bifunctional enzyme that exhibits both NTP:AdoCbi kinase and GTP: AdoCbi-P guanylyltransferase activities 13 . The kinase activity of CobU is necessary for cobinamide (Cbi) salvage but not the de novo synthesis of AdoCbl 10 . So a general conclusion is that it is not AdoCbi that undergoes phosphorylation catalyzed by CobU from S. typhimurium or by CobP from the aerobicpathway-utilizing R. capsulatus; rather, APP is condensed to AdoCby to yield AdoCbi-P. These results strongly suggest that aerobic bacteria and anaerobic bacteria may use the same de novo pathway steps from CBAD to AdoCbl.
Our engineered de novo synthetic pathway for vitamin B12 was successfully constructed in E. coli by assembling six modules comprising many biosynthetic enzymes and four cobalt uptake transport proteins. Although E. coli is a kind of facultative anaerobic bacterium, our study demonstrated that it can be modified to synthesize vitamin B12 using the aerobic pathway. The original recombinant stains produced around 1-2 μg/g DCW of vitamin B12. Subsequently, by strengthening the biosynthesis of precursors and making genetic modifications to cobalt chelatases and Cbi module, we were able to increase the vitamin B12 production to 171.81 µg/g DCW.
It was interesting to note that the expression of cobW (strain FH351) increased vitamin B12 productivity by 49.68-fold, highlighting that cobW plays an important role in cobalt chelation. Vitamin B12 production in FH364 was finally increased to 307.00 µg/g DCW after optimization culture media recipe, growth temperature, and IPTG concentrations; this final yield was 250.64-fold higher than the original strain bearing our engineered The filtrate was then loaded onto an equilibrated Ni Sepharose column (GE Healthcare).
After washing with 10 column volumes of enzyme-trap buffer B (100 mM NaCl, 60 mM imidazole, 20 mM HEPES, pH 7.5), the proteins were eluted using enzyme-trap buffer C (100 mM NaCl, 400 mM imidazole, 20 mM HEPES, pH 7.5). for 60 min. HBAD production was monitored with liquid chromatography/mass spectrometry (LC-MS).
Gene expression and protein production and purification.
In vitro enzyme assay of the CobNST proteins. The CobNST proteins were assayed based on a previously described assay 3 
